AIDS

Article	Citations
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	56
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	55
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	50
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	46
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	46
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	46
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	35
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	34
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	34
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	33
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	33
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	32
Real world use of dolutegravir two drug regimens	29
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	28
Cerebral toxoplasmosis in the twenty-first century	28
Reduced bone density accrual among peripubertal boys with HIV in Zimbabwe: Erratum	27
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	26
Multisector global collaboration to advance the inclusion of pregnant and lactating people in HIV prevention research	26
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	26
A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	26
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	25
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease	25
Trends in population HIV viral suppression: a longitudinal analysis	24
Applying rigorous real-world evidence methodology in HIV medicine: is more evidence needed with long-acting cabotegravir/rilpivirine?	23
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	22

Long-term persistence of transcriptionally active ‘defective’ HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy	22
Cardiovascular outcomes among persons with HIV and nonalcoholic fatty liver disease	21
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	21
Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions	21
Changes in cardiovascular and metabolic risk scores after switching to DOR/3TC/TDF, DTG/3TC or BIC/FTC/TAF: results from a multicenter Italian cohort	21
Life expectancy of people with HIV on antiretroviral therapy in Spain	21
Association of T-cell subtypes with macrophage-specific arterial infiltration in people with HIV	20
Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV	20
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen	20
Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?	20
Age-associated dementia among older people aging with HIV in the United States: a modeling study	20
Association between low bone mass and fracture prevalence among children living with HIV in Africa	20
Fatty liver disease in children living with HIV: a ghostly iceberg	20
Not all costs are the same: understanding costs of opioid agonist treatment around the world	19
Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV	19
A point-of-care tenofovir urine test improves accuracy of self-reported preexposure prophylaxis adherence and increases condomless sex reporting among young women	19
An agricultural livelihood intervention is associated with reduced HIV stigma among people with HIV	19
Metabolic dysfunction-associated steatotic liver disease and liver fibrosis in people with HIV	19
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa	19
The impact of the COVID-19 and mpox outbreaks on behaviours associated with HCV infection among MSM: results from the prerandomisation phase of a clinical trial	19
HIV and herpes simplex virus 2 incidence among adolescent girls and young women who sell sex in rural South Africa	19
The relationship between alcohol consumption and risk of HIV in married men in Sub-Saharan Africa	19
Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV	18
Increased risk of false-positive HIV ELISA results after COVID-19	18
Lower working memory and processing speed among children and youth exposed to HIV	18
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi	18
Social cognition in people with HIV: a neglected cognitive domain?	18
Is baseline genotyping still necessary before initiating long-acting cabotegravir and rilpivirine?	18
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings	18
Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV	17
Sexually transmitted infections in the preexposure prophylaxis era	17
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors	17
Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial	17
‘Zombie’ proviruses in the spotlight: exploring the dark side of HIV persistence	17
Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort	17
Addressing atherosclerotic cardiovascular disease risk in persons with HIV	17
HIV and race are independently associated with endothelial dysfunction	16
The relationship of smoking and unhealthy alcohol use to HIV care retention and viral suppression: findings from a multisite cohort study	16
Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation	16
Local microbiota dysbiosis contributes to the development of high-risk human papillomavirus-associated anal squamous cell carcinoma	16
No cause for complacency regarding health of children who are HIV-exposed but uninfected	16
Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation	16
What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes	16
Potential HIV/ART-mediated germline mutations causing congenital inborn errors of immunity in children born to HIV+ couples: an alarming spectre	16
Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally	16
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis	15
Racial/ethnic disparities in estimated undiagnosed HIV infection among adolescents and adults in the United States, 2017–2021	15
Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic	15
Prevalence and incidence of human papilloma virus-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people with HIV	15
A note of thanks to our reviewers	15

Altered mitochondrial mass and fatty acid uptake by natural killer cells in HIV-exposed uninfected children at 6 years of age	15
Endoplasmic reticulum stress-induced goblet cell apoptosis might contribute to intestinal barrier damage in asymptomatic people with HIV	15
Prevalence and resistance patterns of Mycoplasma genitalium infection in people with HIV: a systematic review and meta-analysis	15
The relationship between HIV and reading performance for children in Tanzania	15
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection	15
High body mass and depression accelerate physical decline in people with HIV: can exercise reverse the clock?	15
Brain N-acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIV	14
Predictors of intact HIV DNA levels among children in Kenya	14
Higher CCR5 density on CD4+ T-cells in mothers and infants is associated with increased risk of in-utero HIV-1 transmission	14
The cumulative prevalence of HIV-1 drug resistance in perinatal HIV	14
Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia	14
Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries	14
Bictegravir/emtricitabine/tenofovir alafenamide after virologic failure to cabotegravir/rilpivirine	14
Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus	14
Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence	14
Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response	14
Obesity in HIV infection: host-pathogen interaction	13
An overview of programmatic indicators to monitor the roll-out of HIV preexposure prophylaxis	13
Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America	13
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017	13
Validity of competing algorithms to identify people with HIV in Medicaid administrative claims: a statewide analysis	13
Sustained viral suppression among people living with HIV in the era of Undetectable = Untransmittable (U = U) in Australia	13
Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy	13
‘With age comes wisdom’: effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV	13
Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support	13
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort	13
Poverty and protection: the relationship between multidimensional poverty, social protection interventions, and HIV viral load	13
Children who are HIV-exposed and uninfected: evidence for action	13
Bone turnover marker trajectories in postpartum women with HIV compared to women without HIV	12
Global health solidarity in the HIV and hypertension disease response	12
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV	12
Dolutegravir regimens have transformed treatment, but ongoing drug resistance research is required to maintain success	12
Association of CD4+ cell count and HIV viral load with risk of non-AIDS-defining cancers	12
Determinants of long-acting cabotegravir plus rilpivirine discontinuation in real-world HIV care: insights from the relativity cohort	12
Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study	12
Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study	12
HIV-1 variants in population-based national surveys in sub-Saharan Africa, 2015–2022	12
Major ECG abnormalities and risk of incident cardiovascular disease in people with HIV compared to people without HIV	12
Hepatitis B core antibody positivity and risk of hepatitis B reactivation following switch of antiretroviral therapy	12
Adolescent girls and young adult women's HIV infection, male partner age, and HIV status: connecting the dots	12
Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection	11
Initial antiretroviral therapy regimen and risk of heart failure: Erratum	11
HIV-1 gp120 exposure associates with mitochondrial and PKM remodeling in cardiomyocytes	11
Auditory and cognitive function in older adults living with and without HIV	11
Risk score prediction for bacteriologically confirmed tuberculosis among adults with HIV on antiretroviral therapy in northwest Ethiopia: prognostic model development	11
Cerebrospinal fluid viral escape can provide clues for the management of HIV-associated neurologic complications: Highlights from the 2023 American Academy of Neurology Annual Meeting, Boston	11
A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders	11
Housing is harm reduction	11
Identification of a novel HIV-1 second-generation circulating recombinant form (CRF136_0107) among MSM in China	11
Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?	11
Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV	11
Risk and predictors of penile cancer in US Veterans with HIV	11
Cervical cancer screening in women with HIV: an audit of clinical care	11
Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs	11
First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort	10
Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats	10
Emergence of in vitro resistance to lenacapavir is similar across HIV-1 subtypes	10
Self-injurious unnatural death among Veterans with HIV	10
Deciphering HIV vaccine-induced antibody response according to ethnicity	10
Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum	10
Longitudinal assessment of inflammatory biomarkers among youth with perinatal HIV infection and HIV exposure	10
Caregiver fears and assumptions about child HIV status drive not testing children for HIV	10
The incidence and dynamic risk factors of chronic kidney disease among people with HIV	10
Associations between HIV serostatus and coronary artery plaque volume progression	10
Soluble CD14 and IL-12p70 on early antiretroviral therapy predict HIV load setpoint after treatment interruption	10
Epstein–Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS	10
Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States	10
Factors associated with survival in patients with lymphoma and HIV	10
HIV-positive donor hearts – a game changer for patients with HIV and organ failure?	10
One-year mortality among adults with advanced HIV in sub-Saharan Africa: a systematic review and meta-analysis	10
Perinatal HIV infection is associated with deficits in muscle function in children and adolescents in Zimbabwe	10
The past that haunts: lessons from missed resistance history	10
HIV-positive Ukrainian refugees in the Czech Republic	10
Fungal diseases are not in the radar of main international HIV conferences	10
Transformative potential of artificial intelligence in US CDC HIV interventions: balancing innovation with health privacy	10
Addressing the burden of HIV-associated chronic lung disease in West Africa	10
Home-based HIV testing strategies for middle-aged and older adults in rural South Africa	10
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes	10
Tuberculosis in children who are HIV-exposed uninfected: A systematic review and metaanalysis	10
Racial disparities in cancer risk among MSM with HIV in the United States	10

Quantifying brain-age gap in people with HIV on antiretroviral therapy using plasma neurofilament light chain	10
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV	9
Severe acute respiratory syndrome coronavirus-2 antibody prevalence in adults with HIV	9
The HIV-2 proviral landscape is dominated by defective proviruses	9
Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action	9
Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV	9
Letter to the editor regarding “Dosing of ritonavir-boosted darunavir for treatment of HIV in pregnancy”	9
Skeletal muscle mitochondrial dysfunction in contemporary antiretroviral therapy: a single cell analysis	9
Impact of a livelihood intervention on gender roles and relationship power among people with HIV	9
Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population	9
Global variations in pubertal growth spurts in adolescents living with perinatal HIV	9
Efficacy of dolutegravir plus lamivudine in treatment-naïve people with HIV with baseline transmitted drug-resistance mutations	9
Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIV	9
The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa	9
Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?	9
Exposure to size-specific particulate matter accelerates DNA methylation aging in people living with HIV	9
Gut microbiome and healthy aging in HIV: data from the correlates of healthy aging in geriatric HIV (CHANGE HIV) cohort	9
Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa	9
Needs for shelter or housing assistance among people with diagnosed HIV by jurisdiction: United States, 2015–2020	9
The application of new metrics for understanding trends in undiagnosed HIV among key populations	9
Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk	9
Food insecurity likely contributes to frailty in people with HIV	9
HIV and mpox: a rapid review	9
Transplantation of kidneys from donors with HIV: are we there yet?	9
New preexposure prophylaxis options need updated counseling approaches: reframing ‘risk’ in HIV prevention counseling for young sexual and gender minorities of color	8
Time-dependent mortality effects of dynamic antiretroviral therapy regimens	8
Contribution of HIV transmission bursts to future HIV infections	8
Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIV	8
Care interruptions and mortality among adults in Europe and North America	8
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice	8
Community PrEP delivery preferences among pregnant and breastfeeding women using oral PrEP in south africa and kenya	8
Risk factors of incident physical frailty in middle-aged and older people with and without HIV: evidence from the CHART cohort	8
Erratum: Clinical and sociodemographic characteristics of Alzheimer's disease and related dementias among people with HIV	8
Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?	8
Sparse data obscure an unchecked Russian HIV epidemic	8
Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries	8
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy	8
Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa	8
Improved screening for pulmonary Kaposi sarcoma in a low-resource setting	8
Initial antiretroviral therapy regimen and risk of heart failure	8
Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa	8
Cabotegravir–rilpivirine treatment initiation in a nonvirologically suppressed patient	8
Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation	8
The lipid research clinics physical activity questionnaire does not accurately measure physical activity in people with HIV	8
Cost-effectiveness of different intervention strategies of HIV in Zhejiang, China	8
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy	8
On the compounding manifestations of racism shaping the US HIV/AIDS epidemic: why ending the HIV epidemic must address these factors for success	8
Dolutegravir-induced neural tube defects in mice are folate responsive	8
Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV	8
Assessing layered HIV prevention programming: optimizing outcomes for adolescent girls and young women	8
A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West Africa	8
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression	8
Persistent immunological repercussions of late antiretroviral initiation in children with HIV	8
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV	8
Incidence of high blood pressure among Kenyan adults with HIV	8
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa	8
Maternal–foetal transfer of severe acute respiratory syndrome coronavirus 2 antibodies among women with and those without HIV infection	8
The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions	7
Quantifying the association of individual-level characteristics with disparities in kidney transplant waitlist addition among people with HIV	7
Persistent or recurrent cervical dysplasia in women living with HIV after treatment for high-grade dysplasia in Botswana	7
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV	7
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa	7
Changes in short-term (in-ICU and in-hospital) mortality following intensive care unit admission in adults living with HIV: 2000–2019	7
Estimating the degree of cardiovascular disease risk under-prediction in people living with HIV by existing risk models: an updated meta-analysis	7
Keeping up with Streptococcus pneumoniae in children living with HIV	7
Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy	7
Deconvoluting the contribution of antiretroviral choice in weight gain	7
What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?	7
Left behind? A longitudinal analysis of need for preexposure prophylaxis services among middle-aged and older adults in South Africa	7
Association between HIV and cancer risk	7
Weight loss associated with semaglutide treatment among people with HIV	7
Neurologic infections in people with HIV: shifting epidemiological and clinical patterns	7
A systematic review of models used to estimate undiagnosed HIV prevalence in high-income low-prevalence countries and territories	7
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV	7
HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks	7
Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment	7
Cost of improved test and treat strategies in Indonesia	7
Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020	7
Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurvey	7
Differential genome-wide associated variants and enriched pathways of ECG parameters among people with versus without HIV	7
Immediate virological failure with intramuscular cabotegravir–rilpivirine in a patient long suppressed with dolutegravir–rilpivirine	7
Islatravir distribution in plasma, peripheral blood mononuclear cells, and mucosal tissues after monthly oral dosing	7
Impaired CD4+ T-cell and CD4+/CD8+ ratio recovery among people with HIV on antiretroviral therapy	7
HIV prevalence in transgender women and cisgender men who have sex with men in sub-Saharan Africa	7
Sexual behaviours and risk with women in MSM in sub-Saharan Africa	7
Low-frequency pre-treatment HIV drug resistance: effects on 2-year outcome of first-line efavirenz-based antiretroviral therapy	7
Safety and efficacy of switching to 4-weekly albuvirtide plus daily dolutegravir in virologically suppressed HIV-1 adults: a 24-week study	7
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV	7
Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder	7
Association between tight junction proteins and cognitive performance in untreated persons with HIV	7
Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy	7
Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass	7
AIDS: changes in leadership	7
Human herpes virus 8-related illness: still with us	7
Intersectional stigmas are associated with lower viral suppression rates and antiretroviral therapy adherence among women living with HIV	7